Melissa A. Geller

Also affiliated with University of Minnesota System, University of Minnesota Medical Center

MedicineImmunology and MicrobiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial”.

Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, Phase III Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02011

N/A

2.6DataRank · unranked

88 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +16 more

A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6003

N/A

0DataRank · unranked

56 citations

Mark F. Brady, Ursula A. Matulonis, Austin Miller, Elise C. Kohn, Elizabeth M. Swisher +15 more

Evaluation of adaptive NK cells in ovarian cancer patients with cytomegalovirus (CMV) reactivation and systemic inflammation.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e18062

N/A

0DataRank · unranked

0 citations

Locke Uppendahl, Martin Felices, Audrey Messelt, DeVon Hunter‐Schlichting, HEATHER H. NELSON +3 more

A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma

UNC Libraries(2020)10.17615/0btq-na91

N/A

0DataRank · unranked

0 citations

Rachel I. Vogel, Elizabeth L. Dickson, Laura J. Havrilesky, Joseph Dottino, Stuart R. Pierce +5 more

Sonosensitizer‐Functionalized Graphene Nanoribbons for Adhesion Blocking and Sonodynamic Ablation of Ovarian Cancer Spheroids

Advanced Healthcare Materials(2021)10.1002/adhm.202001368

N/A

0DataRank · unranked

41 citations

Dae Woo Kim, Victoria O. Jones, Yunkyu Choi, Vivian E. Ferry, Melissa A. Geller +2 more

Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomics

Clinical Proteomics(2021)10.1186/s12014-020-09309-3

N/A

0DataRank · unranked

19 citations

Somaieh Afiuni‐Zadeh, Melissa A. Geller, Peter A. Argenta, Timothy J. Griffin, Amy P.N. Skubitz +1 more

Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation

Translational Oncology(2021)10.1016/j.tranon.2021.101318

N/A

0DataRank · unranked

18 citations

Qianjin Liao, Matt A. Price, Branden S. Moriarity, Natalie K. Wolf, Martin Felices +12 more

Development of a Multiprotein Classifier for the Detection of Early Stage Ovarian Cancer

Cancers(2022)10.3390/cancers14133077

N/A

0DataRank · unranked

66 citations

Ashley Petersen, Timothy K. Starr, Xuan Pu, Melissa A. Geller, Robert C. Bast +8 more

TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004725

N/A

0DataRank · unranked

21 citations

Laura E. Bendzick, Rachel Hopps, Marissa Kauffman, Behiye Kodal, Yvette Soignier +7 more

Prevalence of active cytomegalovirus infection at diagnosis of ovarian cancer and during chemotherapy and subsequent changes in cognitive functioning

BMC Cancer(2023)10.1186/s12885-023-11566-y

N/A

0DataRank · unranked

4 citations

Ashley E. Stenzel, Hee Won Lee, DeVon Hunter‐Schlichting, Erin Wesley, Locke Uppendahl +3 more

Quantification of low-level human cytomegalovirus and Epstein-Barr virus DNAemia by digital PCR

Journal of Virological Methods(2024)10.1016/j.jviromet.2023.114876

N/A

0DataRank · unranked

10 citations

Rachel I. Vogel, Melissa A. Geller, HEATHER H. NELSON, DeVon Hunter‐Schlichting

Associations of cytomegalovirus infection with cancer-related cognitive impairment and peripheral neuropathy in ovarian cancer survivors

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.09.016

N/A

0DataRank · unranked

3 citations

Peter A. Argenta, Katherine Brown, Kate Honeyfield, DeVon Hunter‐Schlichting, Morgan Gruner +6 more

TGF-βRII/IL-15 immunotherapeutic complex targets exhausted CD8 + T-cell subsets in lymph nodes and tumors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013533

N/A

0DataRank · unranked

2 citations

Hing C Wong, Martin Felices, Mark P Rubinstein, Niraj Shrestha, Natalia Valderrama +32 more

1223TiP A randomized phase III study of first-line (1L) trastuzumab deruxtecan (T-DXd) with rilvegostomig or pembrolizumab in patients with HER2-expressing, mismatch repair-proficient (pMMR), primary advanced or recurrent endometrial cancer (EC): DESTINY-Endometrial01/GOG-3098/ENGOT-EN24

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1858

N/A

0DataRank · unranked

1 citations

P. Follana, Melissa A. Geller, Elena Ioana Braicu, S. Ghamande, Ignacio A. Romero +13 more

Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager

Cancer Immunology Research(2020)10.1158/2326-6066.cir-19-0837

N/A

0DataRank · unranked

75 citations

Todd Lenvik, Behiye Kodal, Alexander J. Lenvik, Peter Hinderlie, Laura E. Bendzick +8 more

Bypassing NK cell limitations in the tumor microenvironment through novel Poly-Antigen Cytokine Complexes 2287

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.222

N/A

0DataRank · unranked

0 citations

Melissa Khaw, Marieke van Breukelen, Anders W. Matson, Yvette Soignier, Laura E. Bendzick +10 more